The Effect of Intravenous Lidocaine on Allodynia
CompletedNot applicableNCT00659633
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to study if lidocaine, given intravenously, reduces pain.
Study details
- Official title
- The Effect of Intravenous Lidocaine on Allodynia (Carl Koller Grant)
- Conditions
- Interventions
- Sponsor
- University of Alabama at Birmingham
- Collaborators
- American Society of Regional Anesthesia
- Start date
- 2008-12
- Primary completion
- 2016-06
- Sex
- All
- Age range
- from 19 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Chronic Regional Pain Syndrome diagnostic criteria by the Work Safe BC. vi Exclusion Criteria: * History of Substance abuse * Other Medications: CRPS patients are expected to be treated for chronic pain, whether the current treatment regimen interferes with sensory motor testing will be determined on a case by case basis. * Coronary Artery Disease (CAD): unstable * Congestive Heart Failure (CHF): unstable * Heart Arrhythmia: symptomatic * Chronic Obstructive Pulmonary Disease (COPD) * Lidocaine Allergy * Diagnostic and Statistical Manual of Mental Disorders (Rev IV): Axis I: Common Axis I disorders include depression, anxiety disorders, bipolar disorder, ADHD, and schizophrenia. Axis II: borderline personality disorder, schizotypal personality disorder, antisocial personality disorder, and mild mental retardation. * Presence of Contraindications for MRI * Presence of electronically, magnetically, and mechanically activated implants * Electronically, magnetically, and mechanically activated implants * Ferromagnetic or electronically operated active devices like automatic cardioverter defibrillators * Cardiac pacemakers * Metallic splinters in the eye * Ferromagnetic haemostatic clips in the central nervous system (CNS) * Claustrophobia * Pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00659633